GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Toho Holdings
Who Owns Toho Holdings Company?
Understanding the ownership of Toho Holdings Co., Ltd. is key to grasping its strategic direction and operational influence. Established on September 17, 1948, as Toho Pharmaceutical, the company transitioned to a pure holding company structure in April 2009, renaming itself Toho Holdings.
Headquartered in Tokyo, Japan, Toho Holdings is a leading pharmaceutical wholesaler. Its founders aimed to play a vital role in the healthcare supply chain, ensuring efficient delivery of medical products. The company's operations extend to contract pharmacy services and generic drug manufacturing, as seen in its Toho Holdings BCG Matrix analysis.
As of August 1, 2025, Toho Holdings is publicly traded on the Tokyo Stock Exchange's Prime Market (stock code 8129). It has a market capitalization of $2.11 billion and 62.3 million shares outstanding. The company employs 10,015 individuals and reported $10 billion in trailing 12-month revenue as of March 31, 2025.
Who Founded Toho Holdings?
Toho Holdings Co., Ltd. traces its origins back to September 17, 1948, when it was established as Toho Pharmaceutical. While specific details regarding the individual founders and their initial equity stakes are not publicly detailed, the company's initial operations were centered on pharmaceutical wholesaling. The transition to its current structure as a pure holding company, Toho Holdings, occurred in April 2009.
The company began its journey as Toho Pharmaceutical in 1948. Its initial business was focused on the wholesale distribution of pharmaceuticals.
In April 2009, a significant transformation took place with the company becoming a pure holding company. This marked a strategic shift in its operational and ownership framework.
Information on early backers or angel investors is not readily available. The company's long history suggests a more traditional corporate development path.
The move to a holding company structure in 2009 indicates a strategic consolidation. This structure is designed for managing a group of diverse business units.
The restructuring implies a foundational ownership model geared towards centralized group management. This is typical of mature and expanding enterprises.
As Toho Pharmaceutical, the company operated for many decades before its transformation. This long operational history suggests a stable, evolving ownership structure over time.
The strategic shift to a pure holding company in 2009 signifies a move towards a more centralized ownership and management approach for its various business interests. This evolution from its origins as Toho Pharmaceutical reflects a mature corporate strategy focused on group-level oversight and coordination, rather than direct operational control by the initial founding entity. Understanding the Revenue Streams & Business Model of Toho Holdings provides further context on how this ownership structure supports its diverse operations.
Complete Toho Holdings Strategy Bundle
- 6 Full Frameworks, 1 Company – All Pre-Researched
- Each Framework Fully Sourced with Real Company Data
- Built for Strategy Courses, Case Studies & MBA Programs
- Adapt to Your Assignment – No Starting from Scratch
- 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's
How Has Toho Holdings’s Ownership Changed Over Time?
Toho Holdings Co., Ltd. transformed its structure significantly in April 2009, evolving into a pure holding company and adopting its current name. This strategic move was designed to streamline group operations and boost overall corporate value.
| Shareholder Type | Percentage of Ownership (as of March 31, 2025) |
|---|---|
| Foreign Investors | 33.62% |
| Domestic Companies | 14.18% |
| Financial Institutions | 13.16% |
| Securities Companies | 4.37% |
| Individuals and Others | 34.67% |
The ownership landscape of Toho Holdings Co., Ltd. is characterized by a diverse shareholder base, with individuals and foreign investors holding the largest individual segments as of March 31, 2025. The company's transition to a pure holding structure in 2009 marked a key point in its history, aiming for enhanced group management and corporate value. Understanding the Toho Company shareholders is crucial for grasping its current market position and future direction.
As of recent reporting periods, several institutional investors hold substantial stakes in Toho Holdings. These major investors play a significant role in the company's governance and strategic decisions.
- State Street Bank and Trust Company 505018 is the largest shareholder with 9,646 thousand shares (15.40%).
- The Master Trust Bank of Japan, Ltd. (Trust Account) holds 6,059 thousand shares (9.67%).
- Shionogi & Co., Ltd. possesses 3,500 thousand shares (5.58%).
- 3D WH OPPORTUNITY MASTER OFC – 3D WH OPPORTUNITY HOLDINGS holds 2,400 thousand shares (3.83%).
- Custody Bank of Japan, Ltd. (Trust Account) has 1,494 thousand shares (2.38%).
- Additional significant holdings include 13,905 thousand shares reported by 3D Investment Partners Pte. Ltd. (as of November 14, 2024) and 3,980 thousand shares by Nomura Securities Co., Ltd. and three joint holders (as of April 7, 2025), reflecting substantial investor interest.
The company's market capitalization reached approximately ¥301.1 billion as of May 13, 2025, underscoring its significant presence in the market. This valuation is a reflection of investor confidence and the company's operational performance. For a deeper understanding of how the company aims to achieve its financial goals, exploring the Marketing Strategy of Toho Holdings provides valuable insights into its business approach.
From PESTLE Factors to Full Strategy Bundle
- PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
- Every Strategic Angle Covered – Nothing Left to Research
- Pre-filled with Company-Specific Research
- No Missing Sections for Your Case Study
- One Download Covers Your Entire Company Analysis
Who Sits on Toho Holdings’s Board?
Toho Holdings Co., Ltd. operates with a Board of Directors comprising nine members as of July 4, 2025. This composition includes five outside directors, four of whom are part of the Audit and Supervisory Committee, underscoring a commitment to robust oversight and diverse perspectives in governance.
| Role | Name | Key Responsibilities |
|---|---|---|
| Representative Director, President and CEO | Hiromi Edahiro | Overall management and strategic direction |
| Director | Kamoya | (Specific responsibilities not detailed) |
| Director | Kotani | (Specific responsibilities not detailed) |
| Outside Director | (Multiple) | Strengthening management supervision, diverse viewpoints |
| Audit and Supervisory Committee Member | (Multiple) | Oversight of financial reporting and compliance |
The company's governance framework emphasizes the significant role of independent outside directors in enhancing corporate value and strengthening management supervision. To further bolster governance and strategic planning, Toho Holdings has established specialized committees, including a Governance Enhancement Special Committee and a Management Strategy Committee, both of which integrate independent outside directors. This structure reflects a proactive approach to corporate governance, aiming to ensure accountability and strategic alignment. The company also highlights its commitment to diversity, with three female Directors and two female Corporate Officers appointed as of June 2025. Shareholder engagement is evident, with recommendations from Glass Lewis in June 2025 regarding the reappointment of key executives, including CEO Hiromi Edahiro, indicating active investor interest in the company's leadership and direction. The voting structure generally adheres to the one-share-one-vote principle common in Japan, though specific details on share classes are not publicly detailed. Understanding the nuances of Brief History of Toho Holdings can provide further context on its ownership evolution.
Toho Holdings implements a governance structure designed to enhance oversight and corporate value. The voting power is generally based on a one-share-one-vote system.
- Board composition includes a majority of outside directors for strengthened supervision.
- Special committees with independent directors focus on governance and strategy.
- Commitment to diversity is demonstrated through female executive appointments.
- Shareholder advisory firms provide recommendations on director reappointments.
- The company adheres to the Corporate Governance Code principles.
Toho Holdings Business Model + Strategy Bundle
- Ideal for Essays, Case Studies & Slides
- Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
- Company-Specific Content Already Organized
- One Bundle Replaces Days of Independent Research
- Buy the Bundle Once. Use Across All Your Assignments
What Recent Changes Have Shaped Toho Holdings’s Ownership Landscape?
Over the past few years, Toho Holdings Co., Ltd. has been actively managing its shareholder base and pursuing strategic growth. The company has implemented share buyback programs to enhance shareholder value and has also engaged in significant mergers and acquisitions to expand its presence in the healthcare sector. These actions reflect a dynamic approach to corporate strategy and ownership management.
| Date | Action | Details | Value (¥ million) |
|---|---|---|---|
| August 6, 2024 | Share Repurchase Program | Up to 5,000,000 shares (7.96% of outstanding) | 15,000 |
| March 31, 2025 | Completion of Buyback | 3,405,400 shares acquired | 14,999.47 |
| May 14, 2025 | New Share Repurchase Plan | Up to 3,000,000 shares (4.79% of outstanding) | 10,000 |
| December 31, 2025 | End of New Buyback Plan | ||
| June 30, 2025 | Shares Repurchased (New Plan) | 394,000 shares | 1,807.34 |
| June 1-30, 2025 | Shares Acquired | 263,300 shares | 1,216.312 |
| May 2025 | Acquisition of Pharmo Inc. Stake | 30.30% stake from MTI Ltd. | 900 |
| June 2025 | Capital and Business Alliance | With PHARUMO, Inc. | |
| May 2025 | Business Alliance | With Ishin Pharma Co., Ltd. |
Recent developments indicate a notable shift in the ownership structure of Toho Holdings, with foreign investors increasing their stake significantly. This trend, coupled with activist investor activity, suggests a growing international interest and a more engaged shareholder base. The company's financial performance for the fiscal year ending March 31, 2025, showed modest sales growth, and the increased dividend per share highlights a commitment to rewarding shareholders.
Toho Holdings has actively pursued share repurchase programs, demonstrating a commitment to enhancing shareholder returns. These buybacks aim to improve capital efficiency and boost earnings per share.
The company has strategically expanded its footprint in the pharmaceutical and healthcare sectors through acquisitions and business alliances. These moves are designed to foster consolidation and drive growth.
Foreign institutional ownership has seen a substantial increase, rising from 25.78% in FY2024 to 33.62% in FY2025. This indicates a growing international investor confidence in the company's prospects.
Activist investors, such as 3D Investment Partners, have increased their stake to 20.15%, actively participating in governance and influencing executive management decisions. This engagement highlights a focus on corporate governance and performance improvement.
From Five Forces to Full Company Analysis
- Includes SWOT, PESTLE, BMC, BCG and 4P's
- Pre-Researched with Company-Specific Data
- Best Value for a Complete Analysis
- Ready to Adapt for Your Case Study
- Ready for Essays and Slidesd
- What is Brief History of Toho Holdings Company?
- What is Competitive Landscape of Toho Holdings Company?
- What is Growth Strategy and Future Prospects of Toho Holdings Company?
- How Does Toho Holdings Company Work?
- What is Sales and Marketing Strategy of Toho Holdings Company?
- What are Mission Vision & Core Values of Toho Holdings Company?
- What is Customer Demographics and Target Market of Toho Holdings Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.